The Emerging Role of Anti-Hyperglycemic Agents for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease

The Emerging Role of Anti-Hyperglycemic Agents for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease

Silvia Pieralice,1 Rocco Amendolara,1 Valentina Berna,1 Giuseppina Manganaro,2 Annalisa Zurru,1 Luca D’Onofrio,1 Renata Risi,1 Marianna Alfonsi,1 Ernesto Maddaloni,1 Raffaella Buzzetti1 1Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy; 2Vita- Salute San Raffaele Univers...

Full description

Saved in:
Bibliographic Details
Main Authors: Pieralice S, Amendolara R, Berna V, Manganaro G, Zurru A, D'Onofrio L, Risi R, Alfonsi M, Maddaloni E, Buzzetti R
Format: Article
Language:English
Published: Dove Medical Press 2025-07-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
non-alcoholic fatty liver disease
MASLD
non-alcoholic steatohepatitis
MASH
Type 2 diabetes
anti-hyperglycemic agents
Online Access:https://www.dovepress.com/the-emerging-role-of-anti-hyperglycemic-agents-for-the-management-of-m-peer-reviewed-fulltext-article-DMSO
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/the-emerging-role-of-anti-hyperglycemic-agents-for-the-management-of-m-peer-reviewed-fulltext-article-DMSO

Similar Items